Press Releases about AbbVie![]() ![]() ![]() ![]()
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Friday Morning
February 16, 2024
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Wednesday Morning
February 07, 2024
![]() ![]() ![]()
AbbVie Inc. (NYSE: ABBV) Records 52-Week High Wednesday Morning
January 24, 2024
AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action
January 02, 2024
![]() ![]() ![]() ![]() ![]() ![]() From Brodsky & Smith LLC
Via GlobeNewswire
![]() ![]() ![]() ![]() ![]() ![]()
AbbVie turns a corner; patent cliff fears were overblown
February 02, 2024
Via MarketBeat
Topics
Intellectual Property
Exposures
Intellectual Property
![]() From FN Media Group LLC
Via GlobeNewswire
Via Get News
Exposures
Product Safety
![]() From Brodsky & Smith LLC
Via GlobeNewswire
Via TheNewswire.com
Exposures
Product Safety
![]() From Brodsky & Smith LLC
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|
Kelownadailycourier.ca
Phone number: (250) 763-4000
E-mail: csr@ok.bc.ca
Address: 550 Doyle Avenue
Kelowna, BC V1Y 7V1
© Copyright 2015, Daily Courier, Kelowna, BC. Powered by BLOX Content Management System from TownNews.com.